HYGEIA HEALTH (06078) announced that the company has been granted a general mandate by shareholders at its Annual General Meeting held on June 27, 2025, to repurchase its own shares. Under the buyback authorization, the company is permitted to repurchase up to 61.8499 million shares on the Hong Kong Stock Exchange, representing 10% of the total issued shares (excluding treasury shares) as of the AGM date.

The company believes that the current trading price of its shares does not reflect their intrinsic value or the actual business prospects of HYGEIA HEALTH. Consequently, the board of directors has resolved to utilize the buyback authorization to repurchase shares on the open market from time to time, with a total consideration of no less than RMB 300 million.

HYGEIA HEALTH stated that the proposed share repurchase demonstrates its confidence in the future development of its business. The company's existing financial resources are sufficient to support the buyback while maintaining a sound financial position.

Moving forward, the company will continue to optimize shareholder returns by making more efficient and value-enhancing capital allocation decisions, balancing share repurchases, dividends, and strategic acquisitions based on market conditions.